Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus conversion vs. CIs in liver transplant recipients
NCT00086346Phase 3Terminated
- Sponsor
- Pfizer
- Start
- Dec 2002
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 3 trial of sirolimus in liver transplantation, sponsored by Pfizer. Started Dec 2002; status: terminated.
02
Drugs
sirolimus
03
Conditions
liver transplantation
Beyond the preview
Go deeper on NCT00086346.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00086346.